During uncertain times, your company's controlled substance compliance must remain certain. The Drug Enforcement Administration (DEA) has provided minimal alternatives and waivers to standard security, inventory, record keeping, and reporting requirements, while the ability for registrants to follow established controlled substance practices has been challenged.

Keynote Speakers

Mark Caverly
Sr. Consultant, U.S. Compliance Solutions, IQVIA

Cathy Gallagher
Sr. Consultant, U.S. Compliance Solutions, IQVIA